Royalty Pharma (RPRX) Dividend Yield, Date & History $58.75 -0.47 (-0.79%) As of 01:43 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Dividend Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Royalty Pharma Dividend SummaryDividend Yield1.60%Annual Dividend$0.94Upcoming Ex-Dividend Date Aug. 14 Dividend Increase Track Record 5 YearsAnnualized 5-Year Dividend Growth 24.01%Dividend Payout Ratio 64.83% Royalty Pharma (RPRX) pays quarterly dividends, with an annual dividend of $0.94 per share and a dividend yield of 1.60%. Investors who own the stock before the ex-dividend date of Friday, August 14, 2026 will receive the next quarterly payment of $0.2350 per share, scheduled for Thursday, September 10, 2026. RPRX has grown its dividend for 5 consecutive years, with an average annual increase of 24.01% in the past 5 years. The company currently pays out 64.83% of its earnings and 19.34% of its cash flow as dividends. Skip Charts & View Dividend HistoryRPRX Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Royalty Pharma's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Royalty Pharma in Dividend Calculator RPRX Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Royalty Pharma's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Royalty Pharma in Dividend Yield Calculator Royalty Pharma vs. The CompetitionCompare Royalty Pharma's annual dividend and yield with averages for Healthcare and NASDAQ companies to evaluate its performance against the market.TypeRoyalty PharmaHealthcare CompaniesNASDAQ CompaniesAnnual Dividend$0.94$0.06$1.63Dividend Yield1.59%2.58%10.74%Track Record5 years16 years10 yearsRoyalty Pharma Dividend Payout RatioDividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.TypePayout RatioBased on Trailing 12 Months of Earnings64.83%Based on This Year's Estimate17.74%Based on Next Year's Estimate17.00%Based on Cashflow19.21% Royalty Pharma Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame Start Date End Date Export AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date7/17/2026quarterly$0.2350 - 1.62%8/14/20268/14/20269/10/20264/17/2026quarterly$0.2350 - 1.78%5/15/20265/15/20266/10/20261/9/2026quarterly$0.2350+$0.01506.82%2.08%2/20/20262/20/20263/10/202610/17/2025quarterly$0.22 - 2.25%11/14/202511/14/202512/10/20257/18/2025quarterly$0.22 - 2.48%8/15/20258/15/20259/10/2025What's the Best Way to Lower RMD Taxes? (Ad)Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accounts - and without a plan, those required minimum distributions can carry a serious tax cost. SmartAsset's model suggests working with a fiduciary financial advisor could potentially add 36% to 212% more dollar value to a portfolio over a lifetime. Their no-cost tool matches you with vetted advisors in your area who are legally bound to act in your interest.Find and compare fiduciary financial advisors serving your area today4/21/2025quarterly$0.22 - 2.7%5/16/20255/16/20256/10/20251/9/2025quarterly$0.22+$0.014.76%2.8%2/21/20252/21/20253/10/202510/11/2024quarterly$0.21 - 3%11/15/202411/15/202412/10/2024This table shows Royalty Pharma's quarterly dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Royalty Pharma Dividend - Frequently Asked Questions What is Royalty Pharma's dividend yield? The current dividend yield for Royalty Pharma is 1.59%. Learn more on RPRX's dividend yield history. How much is Royalty Pharma's annual dividend? The annual dividend for RPRX shares is $0.94. Learn more on RPRX's annual dividend history. How often does Royalty Pharma pay dividends? Royalty Pharma pays quarterly dividends to shareholders. When is Royalty Pharma's next dividend payment? Royalty Pharma's next quarterly dividend payment of $0.2350 per share will be made to shareholders on Thursday, September 10, 2026. When was Royalty Pharma's most recent dividend payment? Royalty Pharma's most recent quarterly dividend payment of $0.2350 per share was made to shareholders on Wednesday, June 10, 2026. When is Royalty Pharma's ex-dividend date? Royalty Pharma's next ex-dividend date is Friday, August 14, 2026. When was Royalty Pharma's most recent ex-dividend date? Royalty Pharma's most recent ex-dividend date was Friday, May 15, 2026. Is Royalty Pharma's dividend growing? Over the past five years, the company's dividend has grown by an average of 24.01% per year. What track record does Royalty Pharma have of raising its dividend? Royalty Pharma has increased its dividend for the past 5 consecutive years. When did Royalty Pharma last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.0150 on Friday, January 9, 2026. What is Royalty Pharma's dividend payout ratio? The dividend payout ratio for RPRX is: 64.83% based on the trailing year of earnings 17.74% based on this year's estimates 17.00% based on next year's estimates 19.21% based on cash flow Is Royalty Pharma a good dividend stock? Royalty Pharma's dividend yield of 1.63% is lower than the average Healthcare company that issues a dividend. The company's 5 consecutive years of dividend growth shows that the company has a new, but growing committment to increase its dividend. Royalty Pharma's dividend payout ratio of 64.83% is at a healthy, sustainable level, below 75% of its earnings. Looking at the stock as a whole, market analysts rate Royalty Pharma stock as a Buy, with forecasts suggesting positive growth potential despite some reservations. More Dividend Resources from MarketBeat Related Companies Bristol Myers Squibb Dividend GSK Dividend Sanofi Dividend Zoetis Dividend Viatris Dividend Dr. Reddy's Laboratories Dividend Organon & Co. Dividend Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles Franco-Nevada Earnings: Gold Is Rallying, But Does the Stock Even Care?Ryman Checks Into a $1.38B Hospitality UpgradeParamount’s 30-Film Promise Puts AMC Back in the Box Office Conversation5 Stocks the Market Rewarded After Strong Earnings ResultsMarketBeat Week in Review – 08/03 - 08/07Why Coca-Cola Is Winning While AI Stocks Grab the HeadlinesAlbemarle’s Blowout Quarter Shows Why Lithium Still Matters3 Dividend Champion Utilities for a Market That Can't Sit StillBuild Dividend Income at Low Cost With These ETFs This page (NASDAQ:RPRX) was last updated on 8/13/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get started with MarketBeat. — Hello!Make the most of your MarketBeat account.37% completed. Great work!View a Company's Profile PageView Our Financial CalendarsView Today's Analyst RatingsRead Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant Alert Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
